SCHEMBL26324062

SCHEMBL26324062

CCc1cnc2ccccc2c1Cl

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.45
MAOB P27338 1/20 0.45
KDM4E B2RXH2 1/20 0.42
GPR3 P46089 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
PDE4A P27815 2/20 0.41
PDE4B Q07343 2/20 0.41
PDE4C Q08493 2/20 0.41
PDE4D Q08499 2/20 0.41
LOXL2 Q9Y4K0 1/20 0.39
ERN1 O75460 1/20 0.39
HDAC6 Q9UBN7 1/20 0.38
TNKS2 Q9H2K2 1/20 0.38
GRM5 P41594 2/20 0.37
PKM P14618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11069135 0.83 MAOA (0.47) MAOAMAOBKDM4EGPR3MEN1
SCHEMBL844114 0.83 MAOA (0.47) MAOAMAOBKDM4EGPR3PDE4A
SCHEMBL7849359 0.83 TLR7 (0.43) MAOAMAOBKDM4EGPR3PDE4A
SCHEMBL6526555 0.82 TLR7 (0.48) MAOAMAOBKDM4EPDE4APDE4B
SCHEMBL11063912 0.82 MAOA (0.39) MAOAMAOBKDM4EGPR3PDE4A
SCHEMBL13066703 0.81 MAOA (0.45) MAOAMAOBKDM4EGPR3PDE4A
SCHEMBL28237654 0.81 MAOA (0.45) MAOAMAOBKDM4EGPR3MEN1
SCHEMBL844792 0.81 MAOA (0.45) MAOAMAOBKDM4EGPR3MEN1
SCHEMBL2718503 0.81 ERN1 (0.42) MAOAMAOBKDM4EGPR3MEN1
SCHEMBL22758193 0.79 KDM4E (0.44) KDM4EGPR3MEN1KMT2APDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295114-A1 AKT3 MODULATORS Georgiamune Inc. 2023-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295114-A1 AKT3 MODULATORS AKT3, AKT2, MTOR MAOA 3464/4885MAOB 3235/4885KDM4E 3961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.